Murray Lumpkin
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacology top 5%
- Pharmaceutical industry and healthcare
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmaceutical Economics and Policy 14
- Health Systems, Economic Evaluations, Quality of Life 13
-
- Biotechnology and Related Fields 3
- Pharmaceutical Quality and Counterfeiting 3
- Co-authors
- Jeffrey Shuren (1 shared paper)Michael Friedman (1 shared paper)Janet Woodcock (1 shared paper)Larry J. Thompson (1 shared paper)Vincent I. Ahonkhai (2 shared papers)John C. W. Lim (3 shared papers)Dan Hartman (1 shared paper)Hubert G. M. Leufkens (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Therapeutic Innovation & Regulatory Science (2 papers)Anesthesia & Analgesia (2 papers)PLoS ONE (2 papers)JAMA (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Murray Lumpkin
27 papers receiving 715 citations
Peers
Comparison fields: 5 of 123
- Toxicology 65
- Pharmacology 105
- Geriatrics and Gerontology 39
- Internal Medicine 37
- Economics and Econometrics 240
Countries citing papers authored by Murray Lumpkin
This map shows the geographic impact of Murray Lumpkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray Lumpkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray Lumpkin more than expected).
Fields of papers citing papers by Murray Lumpkin
This network shows the impact of papers produced by Murray Lumpkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray Lumpkin. The network helps show where Murray Lumpkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Murray Lumpkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 176 | |
| 2 | 1998 | 159 | |
| 3 | 1994 | 100 | |
| 4 | 2018 | 72 | |
| 5 | 2016 | 50 | |
| 6 | 2020 | 26 | |
| 7 | Toward a redefinition of psychiatric emergency. | 2000 | 24 |
| 8 | 2020 | 21 | |
| 9 | 2012 | 21 | |
| 10 | 2016 | 18 | |
| 11 | 2019 | 13 | |
| 12 | 2021 | 13 | |
| 13 | 2020 | 11 | |
| 14 | 2015 | 11 | |
| 15 | 2016 | 9 | |
| 16 | 2017 | 8 | |
| 17 | 2000 | 7 | |
| 18 | 2020 | 7 | |
| 19 | 1998 | 7 | |
| 20 | 2025 | 6 |
About Murray Lumpkin
Murray Lumpkin is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Physiology and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 782 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (14 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Biomedical Ethics and Regulation (4 papers), Pharmaceutical studies and practices (3 papers), Pharmaceutical industry and healthcare (3 papers), Biotechnology and Related Fields (3 papers), Pharmaceutical Quality and Counterfeiting (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Toxicology (65 citations), Pharmacology (105 citations), Geriatrics and Gerontology (39 citations), Internal Medicine (37 citations) and Economics and Econometrics (240 citations). Murray Lumpkin has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Jeffrey Shuren, Michael Friedman, Janet Woodcock, Larry J. Thompson, Vincent I. Ahonkhai, John C. W. Lim, Dan Hartman, Hubert G. M. Leufkens, Mike Ward and David J. Robinson. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Therapeutic Innovation & Regulatory Science, Anesthesia & Analgesia, PLoS ONE and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.